A phase 2, randomized, double-blind, placebo-controlled study of the safety and efficacy of EN3835-210 for the treatment of Adhesive Capsulitis Of The Shoulder.
Conquest Research needs volunteers for an investigational trial evaluating a medication designed to help treat patients suffering from Adhesive Capsulitis Of The Shoulder. You may qualify if you:
Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.